Trials / Unknown
UnknownNCT01075022
Effect of a Single Colecalciferol Dose on Insulin Resistance
Effect of a Single Colecalciferol Dose on Insulin Resistance: A Prospective Randomized Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 136 (estimated)
- Sponsor
- Hospital de Clinicas de Porto Alegre · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A Prospective Double-Blinded, Placebo Controlled, Randomized Trial comparing a single dose of Vitamin D (Colecalciferol) 300.00UI to placebo on patients with insulin resistance. Primary Outcome: Blood glucose and homeostasis model assessment for insulin resistance (HOMA-R) after 90 days. Study hypothesis: Vitamin D treatment may improve insulin resistance and decrease glucose level, since there is an association between hypovitaminosis D and increased insulin resistance.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Colecalciferol (Vitamin D3) 300.000 UI | Colecalciferol (Vitamin D3) 300.000 UI Capsule, Single Dose |
| DRUG | Placebo | Placebo Capsule, Single Dose |
Timeline
- Start date
- 2009-05-01
- Primary completion
- 2010-07-01
- Completion
- 2010-07-01
- First posted
- 2010-02-24
- Last updated
- 2010-02-24
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT01075022. Inclusion in this directory is not an endorsement.